In 2006, Smith et al. (63) described for the first time that the promoter region on human chromosome 6q23-q24 of TCF21 was hypermethylated in non-small-cell lung cancers (NSCLC) and head and neck squamous cell carcinomas. This evidence concerns the gene TCF21 and non-small cell lung carcinoma.